RT Journal Article
SR Electronic
T1 Rosuvastatin Only Minimally Effective in Reducing AF in Patients with HF
JF MD Conference Express
YR 2009
FD SAGE Publications
VO 9
IS 4
SP 20
OP 21
DO 10.1177/155989770904013
UL http://mdc.sagepub.com/content/9/4/20.2.abstract
AB This article data from a post hoc analysis of the Effect of rosuvastatin in patients with chronic heart failure [GISSI-HF; NCT00336336] study, showing only modest evidence of a reduction in atrial fibrillation (AF) in heart failure (HF) patients who were treated with rosuvastatin. The aim of the subanalysis was to assess the effect of n-3 PUFA and rosuvastatin compared with placebo in patients with chronic HF who were not in AF at study entry.